loading

Monte Rosa Therapeutics Inc Stock (GLUE) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
1.064
- - - -
Operating Expenses
3.29%
36.01
34.86 36.97 37.22 34.26
Benefits Costs and Expenses
32.95
- - - -
Costs And Expenses
32.95
- - - -
Operating Income/Loss
0.24%
-34.95
-34.86 -36.97 -37.22 -34.26
Nonoperating Income/Loss
92.70%
3.062
1.589 2.254 2.233 2.221
Income/Loss From Continuing Operations Before Tax
4.17%
-31.89
-33.27 -34.71 -34.99 -32.04
Income Tax Expense/Benefit
477.27%
0.083
-0.022 0.17 0.19 -
Income/Loss From Continuing Operations After Tax
3.86%
-31.97
-33.25 -34.88 -35.18 -32.04
Net Income/Loss
3.86%
-31.97
-33.25 -34.88 -35.18 -32.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,128%
60.16
1.8638 49.81 49.43 49.35
Diluted Average Shares
3,128%
60.16
1.8638 49.81 49.43 49.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):